The studies focused on developing an adenosine A2A receptor (A2AR) tracer, with antagonists of A2AR, to evaluate the A2AR upregulation observed in the striatum of PD, which appears to be related to dyskinesia. The gene discussed is ADORA2A; the disease is drug-induced dyskinesia.